IVVD•benzinga•
What's Going On With COVID-19 Antibody Developer Invivyd Stock On Friday?
Summary
Invivyd's new data highlights Pemgarda's activity against SARS-CoV-2 XEC and over 75% of variants, with consistent neutralization since Omicron BA.1.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 10, 2025 by benzinga